These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16009513)
21. Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer. Duvall CL; Convertine AJ; Benoit DS; Hoffman AS; Stayton PS Mol Pharm; 2010 Apr; 7(2):468-76. PubMed ID: 19968323 [TBL] [Abstract][Full Text] [Related]
22. Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules. Yessine MA; Leroux JC Adv Drug Deliv Rev; 2004 Apr; 56(7):999-1021. PubMed ID: 15066757 [TBL] [Abstract][Full Text] [Related]
23. Interaction of an endosomolytic polyamidoamine ISA23 with vesicles mimicking intracellular membranes: A SANS/EPR study. Griffiths PC; Nilmini R; Carter E; Dodds P; Murphy DM; Khayat Z; Lattanzio E; Ferruti P; Heenan RK; King SM; Duncan R Macromol Biosci; 2010 Aug; 10(8):963-73. PubMed ID: 20533532 [TBL] [Abstract][Full Text] [Related]
24. Delivery Strategies for Melittin-Based Cancer Therapy. Zhou J; Wan C; Cheng J; Huang H; Lovell JF; Jin H ACS Appl Mater Interfaces; 2021 Apr; 13(15):17158-17173. PubMed ID: 33847113 [TBL] [Abstract][Full Text] [Related]
25. Conformational studies of anionic melittin analogues: effect of peptide concentration, pH, ionic strength, and temperature--models for protein folding and halophilic proteins. Ramalingam K; Aimoto S; Bello J Biopolymers; 1992 Aug; 32(8):981-92. PubMed ID: 1420981 [TBL] [Abstract][Full Text] [Related]
26. Poly(amidoamine)-mediated intracytoplasmic delivery of ricin A-chain and gelonin. Pattrick NG; Richardson SC; Casolaro M; Ferruti P; Duncan R J Control Release; 2001 Dec; 77(3):225-32. PubMed ID: 11733090 [TBL] [Abstract][Full Text] [Related]
27. Acid-Activated Melittin for Targeted and Safe Antitumor Therapy. Luo L; Wu W; Sun D; Dai HB; Wang Y; Zhong Y; Wang JX; Maruf A; Nurhidayah D; Zhang XJ; Wang Y; Wang GX Bioconjug Chem; 2018 Sep; 29(9):2936-2944. PubMed ID: 30148623 [TBL] [Abstract][Full Text] [Related]
30. The dawning era of polymer therapeutics. Duncan R Nat Rev Drug Discov; 2003 May; 2(5):347-60. PubMed ID: 12750738 [TBL] [Abstract][Full Text] [Related]
31. Polymeric anticancer drugs with pH-controlled activation. Ulbrich K; Etrych T; Chytil P; Pechar M; Jelinkova M; Rihova B Int J Pharm; 2004 Jun; 277(1-2):63-72. PubMed ID: 15158969 [TBL] [Abstract][Full Text] [Related]
32. Injectable poly(amidoamine)-poly(ethylene glycol)-poly(amidoamine) triblock copolymer hydrogel with dual sensitivities: pH and temperature. Nguyen MK; Park DK; Lee DS Biomacromolecules; 2009 Apr; 10(4):728-31. PubMed ID: 19296656 [TBL] [Abstract][Full Text] [Related]
33. Novel endosomolytic poly(amido amine) polymer conjugates for systemic delivery of siRNA to hepatocytes in rodents and nonhuman primates. Parmar RG; Poslusney M; Busuek M; Williams JM; Garbaccio R; Leander K; Walsh E; Howell B; Sepp-Lorenzino L; Riley S; Patel M; Kemp E; Latham A; Leone A; Soli E; Burke RS; Carr B; Colletti SL; Wang W Bioconjug Chem; 2014 May; 25(5):896-906. PubMed ID: 24742200 [TBL] [Abstract][Full Text] [Related]
34. The design and synthesis of polymers for eukaryotic membrane disruption. Murthy N; Robichaud JR; Tirrell DA; Stayton PS; Hoffman AS J Control Release; 1999 Aug; 61(1-2):137-43. PubMed ID: 10469910 [TBL] [Abstract][Full Text] [Related]
35. Modulation of cell membrane disruption by pH-responsive pseudo-peptides through grafting with hydrophilic side chains. Chen R; Yue Z; Eccleston ME; Williams S; Slater NK J Control Release; 2005 Nov; 108(1):63-72. PubMed ID: 16139914 [TBL] [Abstract][Full Text] [Related]
36. The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery. Thompson CJ; Tetley L; Cheng WP Int J Pharm; 2010 Jan; 383(1-2):216-27. PubMed ID: 19766178 [TBL] [Abstract][Full Text] [Related]
37. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bae Y; Nishiyama N; Fukushima S; Koyama H; Yasuhiro M; Kataoka K Bioconjug Chem; 2005; 16(1):122-30. PubMed ID: 15656583 [TBL] [Abstract][Full Text] [Related]
38. Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linker. Lavignac N; Nicholls JL; Ferruti P; Duncan R Macromol Biosci; 2009 May; 9(5):480-7. PubMed ID: 19016501 [TBL] [Abstract][Full Text] [Related]
39. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. Du JZ; Du XJ; Mao CQ; Wang J J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458 [TBL] [Abstract][Full Text] [Related]
40. Conformational and aggregational states of omega-aminoacylmelittin derivatives. Ramalingam K; Bello J Biochemistry; 1993 Jan; 32(1):253-9. PubMed ID: 8418844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]